HN Ginsberg - The Journal of clinical investigation, 2000 - Am Soc Clin Investig
454 The Journal of Clinical Investigation| August 2000| Volume 106| Number 4 uptake and storage by adipocytes, such as those for hormone-sensitive lipase (HSL)(9), lipoprotein …
X Ma, L Dong, Q Shao, Y Cheng, S Lv, Y Sun… - Cardiovascular …, 2020 - Springer
Abstract Background The triglyceride glucose (TyG) index, a simple surrogate estimate of insulin resistance, has been demonstrated to predict cardiovascular (CV) disease morbidity …
TP Patel, K Rawal, AK Bagchi, G Akolkar… - Heart failure …, 2016 - Springer
Sedentary life style and high calorie dietary habits are prominent leading cause of metabolic syndrome in modern world. Obesity plays a central role in occurrence of various diseases …
J Calles-Escandon, M Cipolla - Endocrine reviews, 2001 - academic.oup.com
The main etiology for mortality and a great percent of morbidity in patients with diabetes mellitus is atherosclerosis. A hypothesis for the initial lesion of atherosclerosis is endothelial …
PJ Grant - Journal of internal medicine, 2007 - Wiley Online Library
Diabetes mellitus (DM) is characterized by fasting hyperglycaemia and a high risk of atherothrombotic disorders affecting the coronary, cerebral and peripheral arterial trees. The …
ContextIncreased risk for cardiovascular disease in persons with glucose intolerance (impaired glucose tolerance and type 2 diabetes mellitus) is not fully explained by …
Aim: The intent of this review is to critically analyze the scientific evidence on the role of the glycemic index in chronic Western disease and to discuss the utility of the glycemic index in …
Obese patients are at risk for the development of cardiovascular diseases, which can in part be explained by disturbances in the haemostatic and fibrinolytic systems. Indeed, obese …
T Skurk, H Hauner - International journal of obesity, 2004 - nature.com
Obesity is the central promoter of the metabolic syndrome which also includes disturbed fibrinolysis in addition to hypertension, dyslipidaemia and impaired glucose tolerance/type 2 …